Market cap
$2 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | 18.62 | 25.19 | 4.35 | -7.52 |
| Net Profit | -- | 30.75 | 26.19 | 6.33 | -2.38 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Jul-22 | Jul-21 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -14,661.76 | -8,971.02 | -- | -- | -- |
| Return on equity
| -183.37 | -182.24 | -- | -154.68 | -173.90 |
| Return on Capital
| -145.54 | -159.50 | -- | -118.50 | -134.65 |
| Return on Assets
| -111.21 | -121.28 | -106.20 | -87.47 | -104.82 |
| Debt to Equity (x)
| -- | -- | -0.35 | 1.01 | 0.19 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
--
|
-118.50
|
-134.65
|
-183.48
|
-128.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
--
|
-154.68
|
-173.90
|
-221.51
|
-128.28
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-106.20
Lower than Peers by 75.22
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
-106.20
|
-87.47
|
-104.82
|
-141.33
|
-100.69
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
--
|
--
|
--
|
-14,661.76
|
-19,178.93
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
EBIT Growth
25.19
Higher than Peers by 25.99
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
25.19
|
23.50
|
-11.45
|
-42.71
|
15.76
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
26.19
Higher than Peers by 33.50
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
26.19
|
24.33
|
-6.90
|
-39.56
|
22.64
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-0.35
--
Total debt / Net worth
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
-0.35
|
1.01
|
0.19
|
0.56
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.24
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
-0.24
|
0.33
|
0.05
|
0.11
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.89
Lower than Peers by 4.92
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
0.89
|
2.30
|
6.18
|
2.36
|
5.73
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
0.89
Lower than Peers by 4.81
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
0.89
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-626.66
Lower than Peers by 624.57
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
-626.66
|
-1,768.80
|
-3,051.02
|
-8,488.28
|
-7,993.87
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
0.78
Lower than Peers by 4.40
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
0.78
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.04
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
0.04
|
0.17
|
0.82
|
0.30
|
0.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
2
Lower than Peers by 144
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Jul-22
|
Jul-21
|
Jul-20
|
Jul-19
|
|---|---|---|---|---|---|
|
OncoSec Medical Inc (ONCS)
|
2
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|